Frontiers in Bioengineering and Biotechnology. Tissue Engineering and Regenerative Medicine Marcel Felder, Bettina Trueeb, Andreas O. Stucki, Sarah Borcard, Janick D. Stucki, Bruno Schnyder, Thomas Geiser & and Olivier T. Guenat Abstract The lung alveolar region experiences remodeling during several acute and chronic lung diseases, as for instance idiopathic pulmonary fibrosis (IPF), a fatal disease,…
MoreNeoplasia Colin C. Tièche, Yanyun Gao, Elias D. Bührer, Nina Hobi, Sabina A. Berezowska, Kurt Wyler, Laurène Froment, Stefan Weis, Ren-Wang Peng, Rémy Bruggmann, Primo Schär, Michael A. Amrein, Sean R. R. Hal, Patrick Dorn, Gregor Kocher, Carsten Riether, Adrian Ochsenbein, Ralph A. Schmid & Thomas M. Marti Abstract Cell lines are essential tools to…
MoreAngiogenesis Soheila Zeinali, Colette A Bichsel, Nina Hobi, Manuela Funke, Thomas M Marti, Ralph A Schmid, Olivier T Guenat, Thomas Geiser Abstract Idiopathic pulmonary fibrosis is characterized by a progressive scarring and stiffening of the peripheral lung tissue that decreases lung function. Over the course of the disease, the lung microvasculature undergoes extensive remodeling. There…
MoreToxicology Letters Andreas O. Stucki, Giulia Raggi, Serena Sigrist, Pauline Zamprogno, Nicole Schneider-Daum, Claus Michael-Lehr, Hanno Huwer, Janick D. Stucki, Nina Hobi & Olivier T. Guenat Abstract Introduction: The pulmonary alveolar barrier is one of the largest entry ports for xenobiotics into the body and consists of a thin barrier of epithelial and endothelial cells.…
MoreToxicology Letters Nuria Roldan, Aude Rapet, Andreas O. Stucki, Giulia Raggi, Kleanthis Fytianos, Thomas Geiser, Nina Hobi & Olivier T. Guenat Abstract Acute lung injury (ALI) is a complex lung disease in which inflammation plays a central role. The disruption of the alveolar epithelial-endothelial barrier together with an exacerbated inflammatory response lead to influx of…
MoreScientific Reports Janick D. Stucki, Nina Hobi, Artur Galimov, Andreas O. Stucki, Nicole Schneider-Daum, Claus-Michael Lehr, Hanno Huwer, Manfred Frick, Manuela Funke-Chambour, Thomas Geiser & Olivier T. Guenat Abstract Organs-on-chips have the potential to improve drug development efficiency and decrease the need for animal testing. For the successful integration of these devices in research and…
MoreBiomicrofluidics Olivier T. Guenat & François Berthiaume Abstract In the last decade, the advent of microfabrication and microfluidics and an increased interest in cellular mechanobiology have triggered the development of novel microfluidic-based platforms. They aim to incorporate the mechanical strain environment that acts upon tissues and in-vivo barriers of the human body. This article reviews…
MoreEuropean Journal of Nanomedicine Peter Wick, Savvina Chortarea, Olivier T. Guenat, Matthias Roesslein, Janick D. Stucki, Stephanie Hirn, Alke Petri-Fink & Barbara Rothen-Rutishauser Abstract Engineered nanomaterials have unique and novel properties enabling wide-ranging new applications in nearly all fields of research. As these new properties have raised concerns about potential adverse effects for the environment…
MoreLab on a Chip Andreas O. Stucki, Janick D. Stucki, Sean R. R. Hall, Marcel Felder, Yves Mermoud, Ralph A. Schmid, Thomas Geiser & Olivier T. Guenat Abstract We report a lung-on-a-chip array that mimics the pulmonary parenchymal environment, including the thin alveolar barrier and the three-dimensional cyclic strain induced by breathing movements. The micro-diaphragm…
More